Enzon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Enzon Pharmaceuticals has a total shareholder equity of $46.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $47.7M and $1.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$47.01m |
Equity | US$45.99m |
Total liabilities | US$1.71m |
Total assets | US$47.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ENZN's short term assets ($47.3M) exceed its short term liabilities ($1.7M).
Long Term Liabilities: ENZN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ENZN is debt free.
Reducing Debt: ENZN has not had any debt for past 5 years.
Debt Coverage: ENZN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ENZN has no debt, therefore coverage of interest payments is not a concern.